Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CD147 ELISA Kit (AC3534)
Cat.#: ASET-2123
Specifications
Description Human CD147 ELISA Kit allows for the in vitro quantitative determination of human CD147 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2508 Rat Malondialdehyde ELISA Kit (AC3919) Quantitative inquiry ASET-1287 Rat Creatine Kinase B Type ELISA Kit (AC2698) Quantitative inquiry ASET-1922 Porcine Heme Oxygenase 1 ELISA Kit (AC3333) Quantitative inquiry ASET-1698 Human Copeptin ELISA Kit (AC3109) Quantitative inquiry ASET-1200 Rat ERK2 ELISA Kit (AC2611) Quantitative inquiry ASET-2428 Human Nurr1 ELISA Kit (AC3839) Quantitative inquiry ASET-1921 Mouse Semaphorin 3c ELISA Kit (AC3332) Quantitative inquiry ASET-1923 Rabbit Adiponectin ELISA Kit (AC3334) Quantitative inquiry ASET-1518 Human Optineurin ELISA Kit (AC2929) Quantitative inquiry ASET-1472 Human MEF2A ELISA Kit (AC2883) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket